Error: Could not add to watchlist. X
+ Watchlist

Credit Suisse Lux Global Biotech Innovators Equity Fund

CLBIEHE:LX
259.06
EUR
6.67
2.64%
As of 12:59 AM EDT 7/27/2016
Fund Type
SICAV
52Wk Range
215.07 - 350.67
1 Yr Return
-25.45%
YTD Return
-15.40%
Previous Close
252.39
52Wk Range
215.07 - 350.67
1 Yr Return
-26.31%
YTD Return
-15.40%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 07/27/2016)
259.06
Total Assets (m USD) (on 07/27/2016)
176.442
Inception Date
02/28/2006
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
IRENE BEATRICE PUETTNER
Front Load Fee
5.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.92%
Expense Ratio
2.19%

Top Fund Holdings

Name Position Value % of Fund
44.00 k 12.75 m 7.15
117.28 k 12.37 m 6.94
130.48 k 11.36 m 6.37
67.00 k 10.58 m 5.94
23.00 k 9.18 m 5.15
140.00 k 8.46 m 4.75
52.75 k 7.96 m 4.46
85.44 k 7.66 m 4.30
90.00 k 7.60 m 4.26
70.00 k 6.52 m 3.66
Profile
Credit Suisse Lux Global Biotech Innovators Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
Address
Credit Suisse AG
Kalanderplatz 1
8070 Zurich
Switzerland
Tel: +41 44 333 40 50
Phone
-